🚀 VC round data is live in beta, check it out!
Bumrungrad Hospital Valuation Multiples
Discover revenue and EBITDA valuation multiples for Bumrungrad Hospital and similar public comparables like Option Care Health, RadNet, Narayana Health, Mouwasat and more.
Bumrungrad Hospital Overview
About Bumrungrad Hospital
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
Founded
1980
HQ
Employees
4.2K
Website
Sectors
Financials (LTM)
EV
$4B
Bumrungrad Hospital Financials
Bumrungrad Hospital reported last 12-month revenue of $810M and EBITDA of $320M.
In the same LTM period, Bumrungrad Hospital generated $423M in gross profit, $320M in EBITDA, and $239M in net income.
Revenue (LTM)
Bumrungrad Hospital P&L
In the most recent fiscal year, Bumrungrad Hospital reported revenue of $813M and EBITDA of $324M.
Bumrungrad Hospital expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $810M | XXX | $813M | XXX | XXX | XXX |
| Gross Profit | $423M | XXX | $408M | XXX | XXX | XXX |
| Gross Margin | 52% | XXX | 50% | XXX | XXX | XXX |
| EBITDA | $320M | XXX | $324M | XXX | XXX | XXX |
| EBITDA Margin | 40% | XXX | 40% | XXX | XXX | XXX |
| EBIT Margin | 35% | XXX | 35% | XXX | XXX | XXX |
| Net Profit | $239M | XXX | $240M | XXX | XXX | XXX |
| Net Margin | 30% | XXX | 30% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Bumrungrad Hospital Stock Performance
Bumrungrad Hospital has current market cap of $4B, and enterprise value of $4B.
Market Cap Evolution
Bumrungrad Hospital's stock price is $5.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $4B | 2.4% | XXX | XXX | XXX | $0.30 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBumrungrad Hospital Valuation Multiples
Bumrungrad Hospital trades at 4.9x EV/Revenue multiple, and 12.4x EV/EBITDA.
EV / Revenue (LTM)
Bumrungrad Hospital Financial Valuation Multiples
As of April 18, 2026, Bumrungrad Hospital has market cap of $4B and EV of $4B.
Equity research analysts estimate Bumrungrad Hospital's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Bumrungrad Hospital has a P/E ratio of 18.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 4.9x | XXX | 4.9x | XXX | XXX | XXX |
| EV/EBITDA | 12.4x | XXX | 12.2x | XXX | XXX | XXX |
| EV/EBIT | 13.8x | XXX | 13.8x | XXX | XXX | XXX |
| EV/Gross Profit | 9.4x | XXX | 9.7x | XXX | XXX | XXX |
| P/E | 18.4x | XXX | 18.3x | XXX | XXX | XXX |
| EV/FCF | 21.1x | XXX | 20.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Bumrungrad Hospital Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Bumrungrad Hospital Margins & Growth Rates
Bumrungrad Hospital's revenue in the last 12 month grew by 1%.
Bumrungrad Hospital's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Bumrungrad Hospital's rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Bumrungrad Hospital's rule of X is 45% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Bumrungrad Hospital Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | (1%) | XXX | XXX | XXX |
| EBITDA Margin | 40% | XXX | 40% | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | (1%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 42% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 45% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 14% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 15% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Bumrungrad Hospital Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Bumrungrad Hospital | XXX | XXX | XXX | XXX | XXX | XXX |
| Option Care Health | XXX | XXX | XXX | XXX | XXX | XXX |
| RadNet | XXX | XXX | XXX | XXX | XXX | XXX |
| Narayana Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Mouwasat | XXX | XXX | XXX | XXX | XXX | XXX |
| Aster DM Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Bumrungrad Hospital M&A Activity
Bumrungrad Hospital acquired XXX companies to date.
Last acquisition by Bumrungrad Hospital was on XXXXXXXX, XXXXX. Bumrungrad Hospital acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Bumrungrad Hospital
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBumrungrad Hospital Investment Activity
Bumrungrad Hospital invested in XXX companies to date.
Bumrungrad Hospital made its latest investment on XXXXXXXX, XXXXX. Bumrungrad Hospital invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Bumrungrad Hospital
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Bumrungrad Hospital
| When was Bumrungrad Hospital founded? | Bumrungrad Hospital was founded in 1980. |
| Where is Bumrungrad Hospital headquartered? | Bumrungrad Hospital is headquartered in Thailand. |
| How many employees does Bumrungrad Hospital have? | As of today, Bumrungrad Hospital has over 4K employees. |
| Is Bumrungrad Hospital publicly listed? | Yes, Bumrungrad Hospital is a public company listed on Stock Exchange of Thailand. |
| What is the stock symbol of Bumrungrad Hospital? | Bumrungrad Hospital trades under BH ticker. |
| When did Bumrungrad Hospital go public? | Bumrungrad Hospital went public in 1989. |
| Who are competitors of Bumrungrad Hospital? | Bumrungrad Hospital main competitors are Option Care Health, RadNet, Narayana Health, Mouwasat. |
| What is the current market cap of Bumrungrad Hospital? | Bumrungrad Hospital's current market cap is $4B. |
| What is the current revenue of Bumrungrad Hospital? | Bumrungrad Hospital's last 12 months revenue is $810M. |
| What is the current revenue growth of Bumrungrad Hospital? | Bumrungrad Hospital revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Bumrungrad Hospital? | Current revenue multiple of Bumrungrad Hospital is 4.9x. |
| Is Bumrungrad Hospital profitable? | Yes, Bumrungrad Hospital is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Bumrungrad Hospital? | Bumrungrad Hospital's last 12 months EBITDA is $320M. |
| What is Bumrungrad Hospital's EBITDA margin? | Bumrungrad Hospital's last 12 months EBITDA margin is 40%. |
| What is the current EV/EBITDA multiple of Bumrungrad Hospital? | Current EBITDA multiple of Bumrungrad Hospital is 12.4x. |
| What is the current FCF of Bumrungrad Hospital? | Bumrungrad Hospital's last 12 months FCF is $188M. |
| What is Bumrungrad Hospital's FCF margin? | Bumrungrad Hospital's last 12 months FCF margin is 23%. |
| What is the current EV/FCF multiple of Bumrungrad Hospital? | Current FCF multiple of Bumrungrad Hospital is 21.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.